Heart Health System (Advanced LipiTrim® Ultra, Essential Omega III Fish Oil, TriActive)心血管保健組 - 單盒裝 包括膽固醇及三酸甘油酯保健配方、易善魚油維生素E膠囊食品與心血管強化配方(30天食用量)
- 透過: Market America
- 產品代號: 13847




$109.95 USD
Heart Health心血管保健組包括Heart Health易善魚油維生素E膠囊食品、Heart Health心血管強化配方與Heart 膽固醇及三酸甘油酯保健配方,這些都是專為促進整血管整體健康而設計的。Heart Health易善魚油維生素E膠囊食品每份食用量提供3公克的EPA和DHA,這正是研究結果所顯示的對促進心血管整體健康最有效的份量。Heart Health膽固醇及三酸甘油酯保健配方含有Sytrinol®,這種獨有的專利配方成分提取自天然柑橘多甲氧基黃酮(PMFs)與棕櫚生育三烯醇,專為促進心血管的整體健康而設計。Sytrinol在肝臟内作用,而無需抑制輔酵素Q10的生成。Heart Health膽固醇及三酸甘油酯保健配方是一款強力抗氧化物,有助促進健康濃度的低密度脂蛋白在全身傳輸、正常的膽固醇生長率、健康的總膽固醇值、低密度脂蛋白膽固醇與三酸甘油酯濃度、以及肝臟中正常的三酸甘油酯合成。Heart Health心血管強化配方主要針對三個領域:動脈、膽固醇與同半胱胺酸濃度,促進身體心血管系統的健康。這款獨特配方採用天然成分組合,這些成分已經證實可安全有效地支援動脈功能,並有助維持正常的膽固醇與同半胱胺酸濃度。*†美國食品藥物管理局指出,研究結果(非結論性)表明,食用EPA和DHA omega-3脂肪酸可能減少患冠狀動脈心臟病的風險。
此產品符合免運費或優惠運費資格。
了解更多資訊益處
Heart Health易善魚油維生素E膠囊食品
- 每份日常用量可提供6,000毫克的魚油,其中包含1,800毫克的EPA†與1,200毫克的DHA†
- 有助提振心情
- 有助維持C反應蛋白的健康值
- 有助維持正常血流量
- 有助於維護健康的膽固醇值
- 有助維持血液中正常的三酸甘油酯濃度
- 促進健康膚色
- 促進健康的血壓數值
- 有助整體心血管健康
Heart Health心血管強化配方
- 維生素B群可促進紅血球細胞的健康形成
- 有助維持強健的心肌
- 有助維持正常的同半胱胺酸濃度(可促進心血管與動脈健康)
- 有助於維護健康的膽固醇值
- 促進膽固醇的正常生成率
- 促進健康的膽固醇值與腸道中的膽酸吸收
- 促進腸道內各種脂肪酵素的正常脂肪吸收
- 為低密度脂蛋白粒子提供抗氧化保護
Heart Health膽固醇及三酸甘油酯保健配方
- 抗氧化劑
- 有助促進健康濃度的低密度脂蛋白在全身傳遞
- 促進膽固醇的正常生成率
- 促進健康的總膽固醇值、低密度脂蛋白膽固醇與三酸甘油酯濃度
- 支援肝臟內三酸甘油酯的正常合成
†美國食品藥物管理局指出,研究結果(非結論性)表明,食用EPA和DHA omega-3脂肪酸可能減少患冠狀動脈心臟病的風險。
詳細資料
Heart Health心血管保健組包括Heart Health易善魚油維生素E膠囊食品、Heart Health心血管強化配方與Heart 膽固醇及三酸甘油酯保健配方,這些都是專為促進整血管整體健康而設計的。Heart Health易善魚油維生素E膠囊食品每份食用量提供3公克的EPA和DHA,這正是研究結果所顯示的對促進心血管整體健康最有效的份量。Heart Health膽固醇及三酸甘油酯保健配方含有Sytrinol®,這種獨有的專利配方成分提取自天然柑橘多甲氧基黃酮(PMFs)與棕櫚生育三烯醇,專為促進心血管的整體健康而設計。Sytrinol在肝臟内作用,而無需抑制輔酵素Q10的生成。Heart Health膽固醇及三酸甘油酯保健配方是一款強力抗氧化物,有助促進健康濃度的低密度脂蛋白在全身傳輸、正常的膽固醇生長率、健康的總膽固醇值、低密度脂蛋白膽固醇與三酸甘油酯濃度、以及肝臟中正常的三酸甘油酯合成。Heart Health心血管強化配方主要針對三個領域:動脈、膽固醇與同半胱胺酸濃度,促進身體心血管系統的健康。這款獨特配方採用天然成分組合,這些成分已經證實可安全有效地支援動脈功能,並有助維持正常的膽固醇與同半胱胺酸濃度。*
†美國食品藥物管理局指出,研究結果(非結論性)表明,食用EPA和DHA omega-3脂肪酸可能減少患冠狀動脈心臟病的風險。
成分
A completely new perspective has developed as to the role tocotrienols play in heart health and their importance as a supplement to a healthy diet. Some of the key areas of interest have centered on its role in maintaining and supporting a healthy cardiovascular system by promoting healthy cholesterol, and supporting healthy blood platelet activity. In a recent study that was published in the Journal of Atherosclerosis, researchers at the Kyoto Prefectural University of Medicine in Japan found that tocotrienols were more effective than vitamin E in promoting heart health. The study revealed that tocotrienols accumulate at levels that are 25-95 times greater than alpha tocopherol in human aortic endothelial cells.
Tocotrienols are also potent antioxidants. In human studies, researchers observed that alpha tocotrienols reduced the oxidation of LDL. The antioxidant properties of tocotrienols can mitigate the damage caused by free radicals while protecting cell membranes for better cellular communication. -------------------- A clinical trial consisting of 60 adults showed that four weeks of treatment with 300 mg of patented Sytrinol daily promoted normal levels of total cholesterol, LDL cholesterol, and triglycerides. Follow-up clinical studies have provided further support that Sytrinol promotes cardiovascular health.
†According to the FDA, supportive, but not conclusive, research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease.
常見問答
心血管健康究竟是什麼?
心血管健康(亦稱為心臟健康)指的是心臟血管系統保持在強健且運作良好的狀態中。健康的生活方式與適當的營養補充,能明顯地增加維持心血管健康的機率。
生活型態和心臟健康有何關聯性?
有些簡單、每日可做的事情,有助維護心臟健康。以下事情可維護心臟健康:
- 不吸煙
- 保持健康的體重身高比例
- 飲食中包括大量的水果、蔬菜和全穀類
- 控制總脂肪與飽和脂肪的攝取量
- 規律運動
- 與您的醫護人員一起監控膽固醇、血壓、同半胱胺酸、以及C反應蛋白數值
- 開始採用有助維護心血管健康的完整營養補充計畫
什麼是同半胱胺酸?
同半胱胺酸是心血管健康風險的標記。同半胱胺酸是一種有毒胺基酸,當高濃度地出現在血液中時,與心臟疾病與中風的高風險相關。據專家研究,同半胱胺酸作為心血管疾病的標記,其重要程度與膽固醇值和吸煙因素相同。吸煙和過量飲酒、攝入維生素B群不足可導致同半胱胺酸水平升高,該水平與心血管健康問題相關。
產品內的魚油是否經檢驗證實不含重金屬?
是的。易善魚油維生素E膠囊食品中所用魚油經過兩次測試,由製造商和獨立測試公司各進行一次。本產品中的魚油皆經汞、鉛、多氯聯苯及其他重金屬測試。我們只使用符合或優於加拿大食品檢驗局(CFIA)、歐盟(EU)以及美國可靠營養協會(CRN)標準的魚油。*
此產品是素食產品嗎? 此產品是素食產品嗎?
不是。本產品內含動物膠及魚油。
50%純度指的是什麼?
50%純度指的是魚油、EPA(二十碳五烯酸Omega-3脂肪酸)和DHA(二十二碳六烯酸Omega-3脂肪酸),是現有品質最高的魚油。剩餘的50%是魚油內包含的各種脂肪酸。
為什麼低密度脂蛋白膽固醇被認為是壞的?
當過多的低密度脂蛋白膽固醇存在於血液中,會在通往心臟和大腦的動脈血管內壁緩慢聚積。與其他物質一起形成斑塊,一種可阻塞動脈的濃稠、堅硬的沉澱物。如果凝塊形成並阻塞某條狹窄動脈,則會導致嚴重的心臟問題。
為什麼高密度脂蛋白膽固醇被認為是好的? 大約四分之一到三分之一的血液膽固醇是高密度脂蛋白(HDL)膽固醇。高密度脂蛋白膽固醇被認為是好的膽固醇,是因為當達到高水平值時,其似乎可以預防心臟問題。醫學專家認為高密度脂蛋白能將動脈中的膽固醇運送回肝臟隨後排出體外。還有一些專家認為高密度脂蛋白能清除動脈斑塊中的過量膽固醇,從而減緩沉積。
什麼是三酸甘油酯,其與低密度脂蛋白和高密度脂蛋白有什麼關係?
三酸甘油酯是一種脂肪。來自食物攝取與體內合成。三酸甘油酯值高的人士通常膽固醇水平也較高,因而低密度脂蛋白水平較高,高密度脂蛋白水平較低。
科學
- Fatima N, et al. 2014. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomed 21(5):579-85).
- Fatima N, et al. 2014. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacog Res 6(1):29-35.
- Pingali U, et al. 2013. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A randomized, double-blind, controlled study. Diabetes Met Syndr Obesity: Targets Ther 6:1–10.
- Pingali U, et al. 2014. A comparative study to evaluate the effect of highly standardised aqueous extracts of Phyllanthus emblica, Withania somnifera and their combination on endothelial dysfunction and biomarkers in patients with type II diabetes mellitus. Int J Pharm Sci Res 5(7):2687-2697.
Aceite de Pescado Omega III Esencial con Vitamina E
- Madsen T, Skou HA, et al, C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88:1139-42 (2001)
- Rigelsky, JM, et al, Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm 59:417-22 (2002)
- Kris-Etherton PM, et al, fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23(2):e20-e30 (2003)
- Morris, MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88(2):523-533 (19930
- Howe PR. Dietary fats and hypertension. Focus on fish oil. Ann NY Acad Sci 827:339-352 (1997)
- Morris MC, et al, The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am J Clin Nutr 57(1):59-64 (1993)
- Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. J Engl J Med 320(16):1037-1043 (1989)
- Bonaa, KH, et al, Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tro
- Chan JK, et al, Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. Am J Clin Nutr 53(5):1230-1234 (1991)
- Harris WS, et al, Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism 33(11):1016-1019 (1984)
- Nestel PJ. Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol. Am J Clin Nutr 43(5):752-757 (1986)
- Tsai PJ, Lu SC. Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men. J Formos Med Assoc 96(9):718-726 (1997)
- Garrido A, et al, Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids 24(9):833-835 (1989)
- Siscovick, D.S. et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation 2017, 135: 15. 2017
TriActive
- Bronstrup A et al. Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women. American of Journal Clinical Nutrition 68:1104-10, 1998.
- Brouwer I et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. American of Journal Clinical Nutrition 69:99-104, 1999.
- den Heijer Met al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arteriosclerosis Thrombosis and Vascular Biology 18:356-61, 1998.
- Doshi S et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105(1):22-26, 2002.
- Friso S et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. American of Journal Clinical Nutrition 79(6):992-998, 2004.
- Gouni-Berthold I and Berthold H. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. American Heart Journal 143:356–365, 2002.
- Hatano T et al. Flavan dimers with lipase inhibitory activity from Cassia nomame Phytochemistry 46 (5): 893-900, 1997.
- Kitanaka S. and Takido M. Demethyltorosaflavones C and D from Cassia nomame. Phytochemistry 31:(8) 2927-2929, 1992.
- Mas R et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clinical Pharmacology and Therapeutics 65: 439-47, 1999.
- McCaddon A et al. Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12. Lancet 360:173, 2002.
- McCarty M et al. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. Medical Hypotheses 59(3):268-79, 2002. Review.
- Moghadasian M. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. American Journal of Medicine 107: 588-94, 1999. Review.
- Normen L et al. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. American Journal Clinical Nutrition 71: 908-13, 2000.
- Rigelsky J et al. Hawthorn: pharmacology and therapeutic uses. American Journal of Health-System Pharmacy 59(5):417-22, 2002. Review.
- Schwinger R et al. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP- independently. Journal of Cardiovascular Pharmacology 35(5):700-707, 2000.
- Sinal C and Gonzalez F. Guggulsterone: an old approach to a new problem. Trends in Endocrinology and Metabolism. 13:275-6, 2002.
- Singh R et al. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovascular Drugs and Therapy 4(8):659-664, 1994.
- Tilvis R et al. Serum plant sterols and their relation to cholesterol absorption. American Journal of Clinical Nutrition 43:92-97, 1986.
- Title M et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. Journal of the American College of Cardiology 36:758-765, 2000.
- Urizar N et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296(5573):1703-6, 2002.
- Urizar N et al. Gugulipid: a natural cholesterol-lowering agent. Annual Review in Nutrition 23:303-13, 2003. Review.
- Van den Berg M et al. Combined vitamin B-6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. Journal Vascular Surgery 20(6):933-940, 1994.
- van Oort F et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. American of Journal Clinical Nutrition 77:1318-23, 2003.
- Wald D et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Archives of Internal Medicine 61:695-700, 2001.
- Wang X et al. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis 172(2):239-246, 2004.
- Ward M et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM: An International Journal of Medicine 90:519-24, 1997.
- Woo K et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. American Journal of Medicine 112(7):535-539, 2002.
*上述文字未經美國食品藥物管理局評估。
本產品無意作為診斷、治療或預防任何疾病之用。